Prognosis of symptomatic patients with the A3243G mutation of mitochondrial DNA

Journal of the Formosan Medical Association

Volumn 111, Issue 9, 2012, Pages 489-494

  Liu, Chi Hung ^a   Chang, Chien Hung ^a   Kuo, Hung Chou ^a   Ro, Long Sun ^a   Liou, Chia Wei ^a   Wei, Yau Huei ^b,c   Huang, Chin Chang ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

A3243G mutation; MELAS; Mitochondrial disease; Mitochondrial DNA; Prognosis; Seizures; Taiwanese

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; DEATH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; EPILEPTIC STATE; FEMALE; FOLLOW UP; GENERAL CONDITION DETERIORATION; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MALE; MUSCLE BIOPSY; NEUROLOGIC EXAMINATION; ONSET AGE; POINT MUTATION; PROGNOSIS; PULMONARY HYPERTENSION; RANKIN SCALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; TAIWAN;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; DNA, MITOCHONDRIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUTATION; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES; SEIZURES; STATUS EPILEPTICUS; STROKE; TAIWAN; YOUNG ADULT;

EID: 84867004921     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.06.014     Document Type: Article

References (25)

1. Debray F.G., Lambert M., Chevalier I., Robitaille Y., Decarie J.C., Shoubridge E.A., et al. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 2007, 119:722-733.
2. García-Cazorla A., De Lonlay P., Nassogne M.C., Rustin P., Touati G., Saudubray J.M. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics 2005, 116:1170-1177.
3. Qi Y., Zhang Y., Wang Z., Yang Y., Yuan Y., Niu S., et al. Screening of common mitochondrial mutations in Chinese patients with mitochondrial encephalomyopathies. Mitochondrion 2007, 7:147-150.
4. Huang C.C., Kuo H.C., Chu C.C., Liou C.W., Ma Y.S., Wei Y.H. Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J Biomed Sci 2002, 9:527-533.
5. Bourgeois J.M., Tarnopolsky M.A. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion 2004, 4:441-452.
6. Huang C.C., Chen R.S., Chen C.M., Wang H.S., Lee C.C., Pang C.Y., et al. MELAS syndrome with mitochondrial tRNALeu(UUR) gene mutation in a Chinese family. J Neurol Neurosurg Psychiatry 1994, 57:586-589.
7. Huang C.C., Chen R.S., Chu N.S., Pang C.Y., Wei Y.H. Random mitotic segregation of mitochondrial DNA in MELAS syndrome. Acta Neurol Scand 1996, 93:198-202.
8. Fang W., Huang C.C., Lee C.C., Cheng S.Y., Pang C.Y., Wei Y.H. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol 1993, 53:977-980.
9. Majamaa-Voltti K., Turkka J., Kortelainen M.L., Huikuri H., Majamaa K. Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA. J Neurol Neurosurg Psychiatry 2008, 79:209-211.
10. El Sabbagh S., Lebre A.S., Bahi-Buisson N., Delonlay P., Soufflet C., Boddaert N., et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010, 51:1225-1235.
11. Krähenbühl S., Brandner S., Kleinle S., Liechti S., Straumann D. Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 2000, 20:346-348.
12. Lin C.M., Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 2007, 22:105-109.
13. Lam C.W., Lau C.H., Williams J.C., Chan Y.W., Wong L.J. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediat 1997, 156:562-564.
14. Finsterer J. Treatment of central nervous system manifestations in mitochondrial disorders. Eur J Neurol 2011, 18:28-38.
15. Finsterer J. Management of mitochondrial stroke-like-episodes. Eur J Neurol 2009, 16:1178-1184.
16. Finsterer J., Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010, 12:330-334.
17. Wang W., Seak C.J., Liao S.C., Chiu T.F., Chen J.C. Cardiac tamponade: a new complication in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am J Emerg Med 2008, 26(3):382.e1-382.e2.
18. Sproule D.M., Kaufmann P., Engelstad K., Starc T.J., Hordof A.J., De Vivo D.C. Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 2007, 64:1625-1627.
19. Tay S.H., Nordli D.R., Bonilla E., Null E., Monaco S., Hirano M., et al. Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol 2006, 63:281-283.
20. Majamaa-Voltti K.A., Winqvist S., Remes A.M., Tolonen U., Pyhtinen J., Uimonen S., et al. A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA. Neurol 2006, 66:1470-1475.
21. Scaglia F., Towbin J.A., Craigen W.J., Belmont J.W., Smith E.O., Neish S.R., et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004, 114:925-931.
22. Vydt T.C., de Coo R.F., Soliman O.I., Ten Cate F.J., van Geuns R.J., Vletter W.B., et al. Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 2007, 99:264-269.
23. Sunada Y. Glomerulopathy in MELAS syndrome. Intern Med 2001, 40:561-562.
24. Barclay A.R., Sholler G., Christodolou J., Shun A., Arbuckle S., Dorney S., et al. Pulmonary hypertension-a new manifestation of mitochondrial disease. J Inherit Metab Dis 2005, 28:1081-1089.
25. Wallace D.C. Mitochondria as Chi. Genetics 2008, 179(2):727-735.